1. Home
  2. STVN vs QRVO Comparison

STVN vs QRVO Comparison

Compare STVN & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • QRVO
  • Stock Information
  • Founded
  • STVN 1949
  • QRVO 1957
  • Country
  • STVN Italy
  • QRVO United States
  • Employees
  • STVN N/A
  • QRVO N/A
  • Industry
  • STVN Containers/Packaging
  • QRVO Semiconductors
  • Sector
  • STVN Consumer Discretionary
  • QRVO Technology
  • Exchange
  • STVN Nasdaq
  • QRVO Nasdaq
  • Market Cap
  • STVN 6.6B
  • QRVO 7.1B
  • IPO Year
  • STVN 2021
  • QRVO 1997
  • Fundamental
  • Price
  • STVN $23.20
  • QRVO $79.91
  • Analyst Decision
  • STVN Buy
  • QRVO Hold
  • Analyst Count
  • STVN 6
  • QRVO 19
  • Target Price
  • STVN $25.08
  • QRVO $89.89
  • AVG Volume (30 Days)
  • STVN 294.9K
  • QRVO 1.8M
  • Earning Date
  • STVN 08-05-2025
  • QRVO 07-29-2025
  • Dividend Yield
  • STVN 0.26%
  • QRVO N/A
  • EPS Growth
  • STVN N/A
  • QRVO N/A
  • EPS
  • STVN 0.50
  • QRVO 0.58
  • Revenue
  • STVN $1,215,562,040.00
  • QRVO $3,718,971,000.00
  • Revenue This Year
  • STVN $8.69
  • QRVO $0.51
  • Revenue Next Year
  • STVN $10.67
  • QRVO $5.08
  • P/E Ratio
  • STVN $48.09
  • QRVO $137.60
  • Revenue Growth
  • STVN 3.81
  • QRVO N/A
  • 52 Week Low
  • STVN $16.56
  • QRVO $49.46
  • 52 Week High
  • STVN $25.75
  • QRVO $130.99
  • Technical
  • Relative Strength Index (RSI)
  • STVN 49.43
  • QRVO 56.79
  • Support Level
  • STVN $22.70
  • QRVO $79.33
  • Resistance Level
  • STVN $24.80
  • QRVO $81.50
  • Average True Range (ATR)
  • STVN 1.09
  • QRVO 2.06
  • MACD
  • STVN -0.03
  • QRVO -0.35
  • Stochastic Oscillator
  • STVN 50.79
  • QRVO 56.36

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About QRVO Qorvo Inc.

Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.

Share on Social Networks: